Skip to main content

Articles

Page 12 of 40

  1. Type 2 diabetes (T2D) is a known risk factor for cardiovascular disease (CVD), and CVD is a major cause of mortality in patients with T2D. The CAPTURE study investigated the contemporary (2019) prevalence of e...

    Authors: Sérgio Vencio, André Gustavo Daher Vianna, Mariana Arruda Camara Ferreira da Silva and Dalton Bertolim Precoma
    Citation: Diabetology & Metabolic Syndrome 2022 14:5
  2. The association of polymorphisms in the three genes of SOCS3, JAK2 and STAT3 with genetic susceptibility to type 2 diabetes mellitus (T2DM) was explored, and its interaction with environmental factors such as ...

    Authors: Yang Zhang, Chunwen Lin, Rong Chen, Ling Luo, Jialu Huang, Hao Liu, Weiying Chen, Jian Xu, Haibing Yu and Yuanlin Ding
    Citation: Diabetology & Metabolic Syndrome 2022 14:4
  3. Diabetes is a major cause of worldwide morbidity and mortality. Diet and medication non-adherence are common among individuals with diabetes, making glycemic control difficult to attain. This study aimed to ev...

    Authors: Soheila Ranjbaran, Davoud Shojaeizadeh, Tahereh Dehdari, Mehdi Yaseri and Elham Shakibazadeh
    Citation: Diabetology & Metabolic Syndrome 2022 14:3
  4. Diabetic nephropathy (DN) is the leading cause of end-stage renal disease. Histone lysine-specific demethylase 1 (LSD1) is a flavin-containing amino oxidase that can repress or activate transcription. The aim ...

    Authors: Lina Dong, Lei Yu and Jin Zhong
    Citation: Diabetology & Metabolic Syndrome 2022 14:2
  5. To determine the prevalence of overweight/obesity and associated risk factors in Brazilian adolescents with type 1 diabetes (T1D) and its association with diabetic retinopathy (DR) and chronic kidney disease (...

    Authors: Marilia Brito Gomes, Deborah Conte, Karla Rezende Guerra Drummond, Felipe Mallmann, André Araújo Pinheiro, Franz Schubert Lopes Leal, Paulo Henrique Morales and Carlos Antonio Negrato
    Citation: Diabetology & Metabolic Syndrome 2022 14:1
  6. Diabetic retinopathy (DR) is a diabetic complication and the primary cause of blindness in the world. However, the treatments of DR are challenging given its complicated pathogenesis. Here, we investigated the...

    Authors: Qing Xiao, Yinu Zhao, Hongjing Sun, Jia Xu, Wenjie Li and Limo Gao
    Citation: Diabetology & Metabolic Syndrome 2021 13:152
  7. Gestational diabetes mellitus (GDM) has significant short and long-term health consequences for both the mother and child. There is limited but suggestive evidence that inulin could improve glucose tolerance d...

    Authors: Miao Miao, Yongmei Dai, Can Rui, Yuru Fan, Xinyan Wang, Chong Fan, Juan Mu, Wenwen Hou, Zhiyong Dong, Ping Li, Guiju Sun and Xin Zeng
    Citation: Diabetology & Metabolic Syndrome 2021 13:150
  8. To study the effectiveness of diabetic yoga protocol (DYP) against management of cardiovascular risk profile in a high-risk community for diabetes, from Chandigarh, India.

    Authors: Navneet Kaur, Vijaya Majumdar, Raghuram Nagarathna, Neeru Malik, Akshay Anand and Hongasandra Ramarao Nagendra
    Citation: Diabetology & Metabolic Syndrome 2021 13:149
  9. Diabetes Mellitus is a severe, chronic disease that occurs when blood glucose levels rise above certain limits. Over the last years, machine and deep learning techniques have been used to predict diabetes and ...

    Authors: Luis Fregoso-Aparicio, Julieta Noguez, Luis Montesinos and José A. García-García
    Citation: Diabetology & Metabolic Syndrome 2021 13:148
  10. Since the introduction of the first reusable insulin pen, the advancement in the design of these pens is still ongoing to develop a safe, more efficacious, less painful, and easy to use insulin pen device.

    Authors: Robert Veasey, Carolin A. Ruf, Dmitri Bogatirsky, Jukka Westerbacka, Arnd Friedrichs, Mona Abdel-Tawab, Steffen Adler and Senthilnathan Mohanasundaram
    Citation: Diabetology & Metabolic Syndrome 2021 13:147
  11. Diabetes and hypertension disparities are pronounced among South Asians. There is regional variation in the prevalence of diabetes and hypertension in the US, but it is unknown whether there is variation among...

    Authors: Jeannette M. Beasley, Joyce C. Ho, Sarah Conderino, Lorna E. Thorpe, Megha Shah, Unjali P. Gujral, Jennifer Zanowiak and Nadia Islam
    Citation: Diabetology & Metabolic Syndrome 2021 13:146
  12. Conflicting results of recent studies on the association between Helicobacter pylori (H. pylori) infection and the risk of insulin resistance and metabolic syndrome explored the need for updated meta-analysis on ...

    Authors: Mobin Azami, Hamid Reza Baradaran, Hojat Dehghanbanadaki, Parisa Kohnepoushi, Lotfolah Saed, Asra Moradkhani, Farhad Moradpour and Yousef Moradi
    Citation: Diabetology & Metabolic Syndrome 2021 13:145
  13. This study aims to examine the cross-sectional association between serum total bilirubin (STB) and type 2 diabetes (T2D) risk in the general population, and whether obesity could moderate this association.

    Authors: Yuan Wei, Chaoqun Liu, Fangfang Lai, Shan Dong, Haiyan Chen, Li Chen, Liping Shi, Fengfeng Zhu, Chuangbiao Zhang, Xiuxiu Lv, Shuang Peng and Guang Hao
    Citation: Diabetology & Metabolic Syndrome 2021 13:143
  14. The associations between serum free triiodothyronine (FT3) and diabetic peripheral neuropatprohy (DPN)/carotid atherosclerotic lesions in euthyroid patients with type 2 diabetes are still unclear. The purpose ...

    Authors: Mei-Fang Li, Jiang-Feng Ke, Shuai Li, Jun-Wei Wang, Zhi-Hui Zhu and Jing-Bo Li
    Citation: Diabetology & Metabolic Syndrome 2021 13:142
  15. The involvement of circular RNAs (circRNAs) in diabetic nephropathy (DN) has been gradually identified. In this study, we aimed to explore the functions of circRNA F-box/WD repeat-containing protein 12 (circ-F...

    Authors: Aidong Sun, Ningshuang Sun, Xiao Liang and Zhenbo Hou
    Citation: Diabetology & Metabolic Syndrome 2021 13:141
  16. Similar to other non-communicable diseases (NCDs), people who develop cardiovascular disease (CVD) typically have more than one risk factor. The clustering of cardiovascular risk factors begins in youth, early...

    Authors: Fatima Mezhal, Abderrahim Oulhaj, Abdishakur Abdulle, Abdulla AlJunaibi, Abdulla Alnaeemi, Amar Ahmad, Andrea Leinberger-Jabari, Ayesha S. Al Dhaheri, E. Murat Tuzcu, Eiman AlZaabi, Fatma Al-Maskari, Fatme Alanouti, Fayza Alameri, Habiba Alsafar, Hamad Alblooshi, Juma Alkaabi…
    Citation: Diabetology & Metabolic Syndrome 2021 13:140

    The Correction to this article has been published in Diabetology & Metabolic Syndrome 2024 16:36

  17. Coronary artery disease is a leading cause of morbidity and mortality among patients with diabetes. Previously, we demonstrated that branched-chain amino acids (BCAAs) showed cardioprotective effects against c...

    Authors: Atsushi Morio, Rie Tsutsumi, Shiho Satomi, Takashi Kondo, Hirotsugu Miyoshi, Takahiro Kato, Masashi Kuroda, Tadahiro Kitamura, Kenta Hara, Noboru Saeki, Hiroshi Sakaue and Yasuo M. Tsutsumi
    Citation: Diabetology & Metabolic Syndrome 2021 13:139
  18. FTO gene is considered to play an important role in many metabolic diseases. Evidence from studies indicated the possible association between the FTO rs9939609 polymorphisms with serum lipid profile. Therefore...

    Authors: Vahideh Jalili, Zohreh Mokhtari, Samira Rastgoo, Azadeh Hajipour, Fatemeh Bourbour, Maryam Gholamalizadeh, Alireza Mosavi Jarrahi, Sepehr JavadiKooshesh, Alireza Moslem, Morteza Abdollahi and Saeid Doaei
    Citation: Diabetology & Metabolic Syndrome 2021 13:138
  19. Diabetic nephropathy (DN) is a common complication of diabetes mellitus. Accumulating studies suggest that the deregulation of circular RNA (circRNA) is involved in DN pathogenesis. This study aimed to investi...

    Authors: Rina Wu, Zheli Niu, Guangwei Ren, Lin Ruan and Lijun Sun
    Citation: Diabetology & Metabolic Syndrome 2021 13:137
  20. Coronary artery calcium score and glycated hemoglobin(HbA1c) are both considered risk factors for coronary heart disease. However, the relationship between coronary artery calcium score and HbA1c is still uncl...

    Authors: Jing Yu and Bo Gao
    Citation: Diabetology & Metabolic Syndrome 2021 13:136
  21. Since the development of antiretroviral therapy (ART) with TDF plus 3TC plus EFV, this specific regimen has not been studied enough with long-term lipid and uric acid monitoring.

    Authors: Dafeng Liu, Xinyi Zhang, Jun Kang, Fengjiao Gao, Yinsheng He and Shenghua He
    Citation: Diabetology & Metabolic Syndrome 2021 13:135
  22. As studies on ethnic disparities in metabolic syndrome and its risk factors in Taiwan are still rare, the aims of this study were: (1) to detect the differences in the rates of metabolic syndrome, obesity and ...

    Authors: Chih-Ying Lin, Hui-Jung Hung, Chi-Jung Chung, Chia-Ti Huang, Trong-Neng Wu and Chiu-Ying Chen
    Citation: Diabetology & Metabolic Syndrome 2021 13:134
  23. Growing body of evidence suggest the association between SNP − 11377 C > G and SNP + 276 G > T polymorphisms of adiponectin gene with type 2 diabetes (T2D). However, these findings have not been conclusive and...

    Authors: Mahrokh Alimi, Mohammad Taghi Goodarzi and Mehdi Nekoei
    Citation: Diabetology & Metabolic Syndrome 2021 13:133
  24. Type 2 diabetes mellitus (T2DM) is a major public health concern with growing prevalence with multiple debilitating complications. GlycaCare-II is a proprietary herbal formulation supplement for T2DM containin...

    Authors: Muhammed Majeed, Anju Majeed, Kalyanam Nagabhusahnam, Lakshmi Mundkur and Shaji Paulose
    Citation: Diabetology & Metabolic Syndrome 2021 13:132
  25. Metabolic syndrome is a major public health challenge in both developed and developing countries. The burden of this disease is high, even in patients with psychiatric disorders. However, very little is known ...

    Authors: Dilnessa Fentie, Tariku Derese, Bekele Yazie and Yibeltal Getachew
    Citation: Diabetology & Metabolic Syndrome 2021 13:130
  26. Altered body composition is known to be related to abnormal metabolism. The aim of this study was to determine the association between the fat-to-muscle ratio (FMR) and metabolic disorders in type 2 diabetes (...

    Authors: Dixing Liu, Jiana Zhong, Yuting Ruan, Zhen Zhang, Jia Sun and Hong Chen
    Citation: Diabetology & Metabolic Syndrome 2021 13:129
  27. Albumin, along with other proteins, is abnormally eliminated via the urine during early stages of diabetic nephropathy. Moreover, endothelial dysfunction (ED) accompanying early diabetic nephropathy may develo...

    Authors: José Juan Sánchez-Hidalgo, Juan Antonio Suárez-Cuenca, José Juan Lozano-Nuevo, Víctor Hugo García-López, María Graciela Leal-Gutiérrez, Sein Antonio León-Angel, María Leslye Ramírez-Villa, Martha Elena Rodea-Rubio, José Enrique González-Hernández, José Antonio Canela-Mayoral, Eduardo Murillo-Heredia, Eduardo Vera-Gómez, Alejandro Hernández-Patricio, Carlos Ramiro Zamora-Alemán, Gabriela Alexandra Domínguez-Pérez, Juan Ariel Gutiérrez-Buendia…
    Citation: Diabetology & Metabolic Syndrome 2021 13:128
  28. Both pulmonary tuberculosis (PTB) and diabetes mellitus (DM) are major global public health problems. We estimated the global, regional, and national prevalence of diabetes mellitus in a population with PTB.

    Authors: Minmin Li, Tao Chen, Zhongqiu Hua, Hong Yan, Duolao Wang, Zhaoqing Li, Yijun Kang, Ni Zhu and Chao Li
    Citation: Diabetology & Metabolic Syndrome 2021 13:127
  29. Post-transplant diabetes mellitus (PTDM) occurs in 10–30% of kidney transplant recipients. However, its impact on mortality and graft survival is still ambiguous. Therefore, the current study aimed to analyze ...

    Authors: Hailing Lin, Jiqiang Yan, Lei Yuan, Beibei Qi, Zhujing Zhang, Wanlu Zhang, Aihua Ma and Fuwan Ding
    Citation: Diabetology & Metabolic Syndrome 2021 13:126
  30. Gestational diabetes mellitus (GDM) is the most frequent medical complication of pregnancy. This condition is manifested by glucose intolerance resulting in hyperglycemia of variable severity during pregnancy....

    Authors: Yaer Chen, Chunbo Qiu, Jie Chen, Lu Li, Jichao Xu and Zhiren Sheng
    Citation: Diabetology & Metabolic Syndrome 2021 13:125
  31. Regular physical exercise can improve insulin resistance in insulin target tissues. However, the mechanisms about the beneficial effect of exercise on insulin resistance are not yet fully resolved. This study ...

    Authors: Zhengxi Huang, Jialing Tang and Kai Ji
    Citation: Diabetology & Metabolic Syndrome 2021 13:124
  32. People with diabetes are at a greater risk of serious complications from Coronavirus disease (COVID-19). Self-management of diabetes is therefore of paramount importance. The purpose of this study is to compar...

    Authors: Shahina Pardhan, Md. Saiful Islam, Guillermo F. López-Sánchez, Tirthalal Upadhyaya and Raju P. Sapkota
    Citation: Diabetology & Metabolic Syndrome 2021 13:123
  33. Non-alcoholic fatty liver disease (NAFLD) patients are at a substantial risk for developing cardiovascular disease (CVD). High-density lipoprotein (HDL) is well known to have protective effects against the dev...

    Authors: Sara Karami, Hossein Poustchi, Negar Sarmadi, Amir Reza Radmard, Fatemeh Ali Yari, Abbas Pakdel and Parisa Shabani
    Citation: Diabetology & Metabolic Syndrome 2021 13:121
  34. One possible reason for increased mortality due to SARS-CoV-2 in patients with diabetes is from the complication of diabetic ketoacidosis (DKA).

    Authors: Saad Alhumaid, Abbas Al Mutair, Zainab Al Alawi, Ali A. Rabaan, Mohammed A. Alomari, Sadiq A. Al Salman, Ahmed S. Al-Alawi, Mohammed H. Al Hassan, Hesham Alhamad, Mustafa A. Al-kamees, Fawzi M. Almousa, Hani N. Mufti, Ali M. Alwesabai, Kuldeep Dhama, Jaffar A. Al-Tawfiq and Awad Al-Omari
    Citation: Diabetology & Metabolic Syndrome 2021 13:120
  35. Time in range (TIR) is advocated as key metric of glycemic control and is reported to be associated with microvascular complications of diabetes. Sudomotor dysfunction is among the earliest detectable diabetic...

    Authors: Zhou-qin Feng, Qing-yu Guo, Wei Wang, Yan-yu Yuan, Xu-guang Jin, Hui Zhou, Jun Liu, Hai-yan Lei, Xin-yi Yang, Jun Liu, Bin Lu, Jia-qing Shao and Ping Gu
    Citation: Diabetology & Metabolic Syndrome 2021 13:119
  36. Type 1 diabetes (T1D) is a major risk factor for cardiovascular disease (CVD). Matrix metalloproteinase-14 (MMP-14) is involved in the development of atherosclerosis and CVD. The main aim was to explore the as...

    Authors: Eva Olga Melin, Jonatan Dereke and Magnus Hillman
    Citation: Diabetology & Metabolic Syndrome 2021 13:118
  37. The bone formation ability of type 2 diabetes is inhibited, and exercise can effectively improve the bone formation of T2DM. However, whether exercise can mediate the Wnt3a/β-catenin pathway to improve the mec...

    Authors: Xianghe Chen, Kang Yang, Peng Sun, Renqing Zhao, Bo Liu and Pengcheng Lu
    Citation: Diabetology & Metabolic Syndrome 2021 13:116
  38. Hypertension and diabetes are among the most important risk factors of cardiovascular diseases. Klotho and SIRT1 are known as anti-aging factors with beneficial effects on cardiovascular system. In this study ...

    Authors: Mahboobeh Yeganeh-Hajahmadi, Hamid Najafipour, Farzaneh Rostamzadeh and Ahmad Naghibzadeh-Tahami
    Citation: Diabetology & Metabolic Syndrome 2021 13:115
  39. A variety of health problems, such as metabolic syndrome (MetS), have been linked to sleep disorders. While numerous epidemiological studies have shown a U-shaped relationship between sleep duration and poor h...

    Authors: Shideh Rafati, Maryam Isheh, Abnoos Azarbad, Farhad Ghadiri Soufi, Arash Rahimi and Masoumeh Kheirandish
    Citation: Diabetology & Metabolic Syndrome 2021 13:114
  40. It has been described that physiological changes in glucose metabolism, represented by insulin resistance (IR), are predicted during pubertal evolution, and obesity may be associated with its persistence even ...

    Authors: Ivanice Fernandes Barcellos Gemelli, Thais Rasia Silva, Edson dos Santos Farias, Maria Teresa Anselmo Olinto and Poli Mara Spritzer
    Citation: Diabetology & Metabolic Syndrome 2021 13:113
  41. Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of liver transaminases elevation and a global health concern.

    Authors: Maryam jarhahzadeh, Pezhman Alavinejad, Farnaz Farsi, Durdana Husain and Afshin Rezazadeh
    Citation: Diabetology & Metabolic Syndrome 2021 13:112
  42. Periodontal disease is one of the most frequent comorbidities in diabetic patients and can contribute to poor blood glucose control.

    Authors: Diana Vilela Azzi, Andressa Naira de Jesus Pereira, Viviam de Oliveira Silva, Renata de Carvalho Foureaux, Andressa Ribeiro Veiga Lima, Robson Sfaciotti Barducci, Adriana Silva Albuquerque, Gabriel Lasmar Reis, Raphael Ricon de Oliveira, Eric Francelino Andrade, Márcio Gilberto Zangeronimo, Antonio Chalfun-Júnior and Luciano José Pereira
    Citation: Diabetology & Metabolic Syndrome 2021 13:111
  43. Obesity is a complex disease with an increasing prevalence worldwide. There are different weight-management options for obesity treatment, including dietary control, exercise, surgery, and medication. Medica...

    Authors: Nader Salari, Samira Jafari, Niloofar Darvishi, Elahe Valipour, Masoud Mohammadi, Kamran Mansouri and Shamarina Shohaimi
    Citation: Diabetology & Metabolic Syndrome 2021 13:110

    The Correction to this article has been published in Diabetology & Metabolic Syndrome 2022 14:68

  44. The present study performed two distinct meta-analyses with common outcomes (sperm parameters); one was performed in obese individuals (and non-obese controls) and the other in diabetic individuals (and non-di...

    Authors: Ou Zhong, Lin Ji, Jinyuan Wang, Xiaocan Lei and Hua Huang
    Citation: Diabetology & Metabolic Syndrome 2021 13:109

New Content Item

The official journal of the Brazilian Diabetes Society.

Annual Journal Metrics

  • 2022 Citation Impact
    4.8 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.476 - SNIP (Source Normalized Impact per Paper)
    1.195 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    87 days submission to accept (Median)

    2023 Usage 
    1,322,026 downloads
    1,058 Altmetric mentions